|
1
|
Global Burden of Disease Cancer
Collaboration, ; Fitzmaurice C, Dicker D, Pain A, Hamavid H,
Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, et
al: The global burden of cancer 2013. JAMA Oncol. 1:505–527. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miki Y, Yashiro M, Ando K, Okuno T,
Kitayama K, Masuda G, Tamura T, Sakurai K, Toyokawa T, Kubo N, et
al: Examination of cancer cells exposed to gastric serosa by
serosal stamp cytology plus RT-PCR is useful for the identification
of gastric cancer patients at high risk of peritoneal recurrence.
Surg Oncol. 26:352–358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Togano S, Yashiro M, Miki Y, Yamamoto Y,
Sera T, Kushitani Y, Sugimoto A, Kushiyama S, Nishimura S, Kuroda
K, et al: Microscopic distance from tumor invasion front to serosa
might be a useful predictive factor for peritoneal recurrence after
curative resection of T3-gastric cancer. PLoS One. 15:e02259582020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kinoshita H, Yashiro M, Fukuoka T,
Hasegawa T, Morisaki T, Kasashima H, Masuda G, Noda S and Hirakawa
K: Diffuse-type gastric cancer cells switch their driver pathways
from FGFR2 signaling to SDF1/CXCR4 axis in hypoxic tumor
microenvironments. Carcinogenesis. 36:1511–1520. 2015.PubMed/NCBI
|
|
5
|
Lee HJ and Jo DY: The role of the
CXCR4/CXCL12 axis and its clinical implications in gastric cancer.
Histol Histopathol. 27:1155–1161. 2012.PubMed/NCBI
|
|
6
|
Muller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gockel I, Schimanski CC, Heinrich C,
Wehler T, Frerichs K, Drescher D, von Langsdorff C, Domeyer M,
Biesterfeld S, Galle PR, et al: Expression of chemokine receptor
CXCR4 in esophageal squamous cell and adenocarcinoma. BMC Cancer.
6:2902006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Engl T, Relja B, Blumenberg C, Müller I,
Ringel EM, Beecken WD, Jonas D and Blaheta RA: Prostate tumor
CXC-chemokine profile correlates with cell adhesion to endothelium
and extracellular matrix. Life Sci. 78:1784–1793. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu QY, Yang CK, Rong LJ, Li JC and Lei LM:
Investigation of the association between C-X-C motif chemokine
receptor subunits and tumor infiltration levels and prognosis in
patients with early-stage pancreatic ductal adenocarcinoma. Oncol
Lett. 20:162020.PubMed/NCBI
|
|
10
|
Katsumoto K and Kume S: The role of
CXCL12-CXCR4 signaling pathway in pancreatic development.
Theranostics. 3:11–17. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Scala S, Giuliano P, Ascierto PA, Ieranò
C, Franco R, Napolitano M, Ottaiano A, Lombardi ML, Luongo M,
Simeone E, et al: Human melanoma metastases express functional
CXCR4. Clin Cancer Res. 12:2427–2433. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang SS, Han ZP, Jing YY, Tao SF, Li TJ,
Wang H, Wang Y, Li R, Yang Y, Zhao X, et al:
CD133+CXCR4+ colon cancer cells exhibit
metastatic potential and predict poor prognosis of patients. BMC
Med. 10:852012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chiaramonte R, Colombo M, Bulfamante G,
Falleni M, Tosi D, Garavelli S, De Simone D, Vigolo E, Todoerti K,
Neri A and Platonova N: Notch pathway promotes ovarian cancer
growth and migration via CXCR4/SDF1alpha chemokine system. Int J
Biochem Cell Biol. 66:134–140. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cavallaro S: CXCR4/CXCL12 in
non-small-cell lung cancer metastasis to the brain. Int J Mol Sci.
14:1713–1727. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kitayama K, Yashiro M, Morisaki T, Miki Y,
Okuno T, Kinoshita H, Fukuoka T, Kasashima H, Masuda G, Hasegawa T,
et al: Pyruvate kinase isozyme M2 and glutaminase might be
promising molecular targets for the treatment of gastric cancer.
Cancer Sci. 108:2462–2469. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kato Y, Yashiro M, Noda S, Kashiwagi S,
Matsuoka J, Fuyuhiro Y, Doi Y and Hirakawa K: Expression of a
hypoxia-associated protein, carbonic anhydrase-9, correlates with
malignant phenotypes of gastric carcinoma. Digestion. 82:246–251.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Noda S, Yashiro M, Nshii T and Hirakawa K:
Hypoxia upregulates adhesion ability to peritoneum through a
transforming growth factor-beta-dependent mechanism in diffuse-type
gastric cancer cells. Eur J Cancer. 46:995–1005. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matsuoka J, Yashiro M, Doi Y, Fuyuhiro Y,
Kato Y, Shinto O, Noda S, Kashiwagi S, Aomatsu N, Hirakawa T, et
al: Hypoxia stimulates the EMT of gastric cancer cells through
autocrine TGFβ signaling. PLoS One. 8:e623102013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hirakawa T, Yashiro M, Doi Y, Kinoshita H,
Morisaki T, Fukuoka T, Hasegawa T, Kimura K, Amano R and Hirakawa
K: Pancreatic fibroblasts stimulate the motility of pancreatic
cancer cells through IGF1/IGF1R signaling under hypoxia. PLoS One.
11:e01599122016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kasashima H, Yashiro M, Kinoshita H,
Fukuoka T, Morisaki T, Masuda G, Sakurai K, Kubo N, Ohira M and
Hirakawa K: Lysyl oxidase is associated with the
epithelial-mesenchymal transition of gastric cancer cells in
hypoxia. Gastric Cancer. 19:431–442. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kasashima H, Yashiro M, Nakamae H,
Kitayama K, Masuda G, Kinoshita H, Fukuoka T, Hasegawa T, Nakane T,
Hino M, et al: CXCL1-Chemokine (C-X-C Motif) receptor 2 signaling
stimulates the recruitment of bone marrow-derived mesenchymal cells
into diffuse-type gastric cancer stroma. Am J Pathol.
186:3028–3039. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kasashima H, Yashiro M, Nakamae H, Masuda
G, Kinoshita H, Morisaki T, Fukuoka T, Hasegawa T, Sakurai K,
Toyokawa T, et al: Bone marrow-derived stromal cells are associated
with gastric cancer progression. Br J Cancer. 113:443–452. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yashiro M, Matsuoka T and Ohira M: The
significance of scirrhous gastric cancer cell lines: The molecular
characterization using cell lines and mouse models. Hum Cell.
31:271–281. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Okuno T, Yashiro M, Masuda G, Togano S,
Kuroda K, Miki Y, Hirakawa K, Ohsawa M, Wanibuchi H and Ohira M:
Establishment of a new scirrhous gastric cancer cell line with
FGFR2 overexpression, OCUM-14. Ann Surg Oncol. 26:1093–1102. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Oh YS, Kim HY, Song IC, Yun HJ, Jo DY, Kim
S and Lee HY: Hypoxia induces CXCR4 expression and biological
activity in gastric cancer cells through activation of
hypoxia-inducible factor-1α. Oncol Rep. 28:2239–2246. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Romain B, Hachet-Haas M, Rohr S, Brigand
C, Galzi JL, Gaub MP, Pencreach E and Guenot D: Hypoxia
differentially regulated CXCR4 and CXCR7 signaling in colon cancer.
Mol Cancer. 13:582014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Japanese Gastric Cancer Association:
Japanese classification of gastric carcinoma: 3rd English edition.
Gastric Cancer. 14:101–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Greene FL and Sobin LH: A worldwide
approach to the TNM staging system: Collaborative efforts of the
AJCC and UICC. J Surg Oncol. 99:269–272. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shephard DA: The 1975 declaration of
helsinki and consent. Can Med Assoc J. 115:1191–1192.
1976.PubMed/NCBI
|
|
30
|
Eckert AW, Horter S, Bethmann D, Kotrba J,
Kaune T, Rot S, Bache M, Bilkenroth U, Reich W, Greither T, et al:
Investigation of the prognostic role of carbonic anhydrase 9 (CAIX)
of the cellular mRNA/protein level or soluble CAIX protein in
patients with oral squamous cell carcinoma. Int J Mol Sci.
20:3752019. View Article : Google Scholar
|
|
31
|
Hitchon C, Wong K, Ma G, Reed J, Lyttle D
and El-Gabalawy H: Hypoxia-induced production of stromal
cell-derived factor 1 (CXCL12) and vascular endothelial growth
factor by synovial fibroblasts. Arthritis Rheum. 46:2587–2597.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu H, Liu S, Li Y, Wang X, Xue W, Ge G
and Luo X: The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic
effects of hypoxia-preconditioned mesenchymal stem cells for renal
ischemia/reperfusion injury. PLoS One. 7:e346082012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tashiro K, Tada H, Heilker R, Shirozu M,
Nakano T and Honjo T: Signal sequence trap: A cloning strategy for
secreted proteins and type I membrane proteins. Science.
261:600–603. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Iwasa S, Yanagawa T, Fan J and Katoh R:
Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric
cancer is associated with lymph node and liver metastasis.
Anticancer Res. 29:4751–4758. 2009.PubMed/NCBI
|
|
35
|
Zhao BC, Wang ZJ, Mao WZ, Ma HC, Han JG,
Zhao B and Xu HM: CXCR4/SDF-1 axis is involved in lymph node
metastasis of gastric carcinoma. World J Gastroenterol.
17:2389–2396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yasumoto K, Koizumi K, Kawashima A, Saitoh
Y, Arita Y, Shinohara K, Minami T, Nakayama T, Sakurai H, Takahashi
Y, et al: Role of the CXCL12/CXCR4 axis in peritoneal
carcinomatosis of gastric cancer. Cancer Res. 66:2181–2187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Koshiba T, Hosotani R, Miyamoto Y, Ida J,
Tsuji S, Nakajima S, Kawaguchi M, Kobayashi H, Doi R, Hori T, et
al: Expression of stromal cell-derived factor 1 and CXCR4 ligand
receptor system in pancreatic cancer: A possible role for tumor
progression. Clin Cancer Res. 6:3530–3535. 2000.PubMed/NCBI
|
|
38
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang Q, Sun Y and Liu X: CXCR4 as a
prognostic biomarker in gastrointestinal cancer: A meta-analysis.
Biomarkers. 24:510–516. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu C and Zhang Y: Characterization of the
prognostic values of CXCR family in gastric cancer. Cytokine.
123:1547852019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ishigami S, Natsugoe S, Okumura H,
Matsumoto M, Nakajo A, Uenosono Y, Arigami T, Uchikado Y, Setoyama
T, Arima H, et al: Clinical implication of CXCL12 expression in
gastric cancer. Ann Surg Oncol. 14:3154–3158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nayak A, Roy AD, Rout N, Singh SP,
Bhattacharyya A and Roychowdhury A: HIF1α-dependent upregulation of
ATAD2 promotes proliferation and migration of stomach cancer cells
in response to hypoxia. Biochem Biophys Res Commun. 523:916–923.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
de Barros Moreira Beltrão H, de Paula
Cerroni M, de Freitas DR, das Neves Pinto AY, da Costa Valente V,
Valente SA, de Góes Costa E and Sobel J: Investigation of two
outbreaks of suspected oral transmission of acute chagas disease in
the amazon region, para state, Brazil, in 2007. Trop Doct.
39:231–232. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li Q, Zhu CC, Ni B, Zhang ZZ, Jiang SH, Hu
LP, Wang X, Zhang XX, Huang PQ, Yang Q, et al: Lysyl oxidase
promotes liver metastasis of gastric cancer via facilitating the
reciprocal interactions between tumor cells and cancer associated
fibroblasts. EBioMedicine. 49:157–171. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bubnovskaya L and Osinsky D: Tumor
microenvironment and metabolic factors: Contribution to gastric
cancer. Exp Oncol. 42:2–10. 2020.PubMed/NCBI
|
|
46
|
Zhang WJ, Chen C, Zhou ZH, Gao ST, Tee TJ,
Yang LQ, Xu YX, Pang TH, Xu XY, Sun Q, et al: Hypoxia-inducible
factor-1 alpha correlates with tumor-associated macrophages
infiltration, influences survival of gastric cancer patients. J
Cancer. 8:1818–1825. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kato Y, Yashiro M, Fuyuhiro Y, Kashiwagi
S, Matsuoka J, Hirakawa T, Noda S, Aomatsu N, Hasegawa T, Matsuzak
T, et al: Effects of acute and chronic hypoxia on the
radiosensitivity of gastric and esophageal cancer cells. Anticancer
Res. 31:3369–3375. 2011.PubMed/NCBI
|
|
48
|
Al-Juboori SI, Vadakekolathu J, Idri S,
Wagner S, Zafeiris D, Rd Pearson J, Almshayakhchi R, Caraglia M,
Desiderio V, Miles AK, et al: PYK2 promotes HER2-positive breast
cancer invasion. J Exp Clin Cancer Res. 38:2102019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu S, Jia X, Li C, Han X, Yan W and Xing
Y: CXCR7 silencing attenuates cell adaptive response to stromal
cell derived factor 1alpha after hypoxia. PLoS One. 8:e552902013.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kato Y, Yashiro M, Noda S, Tendo M,
Kashiwagi S, Doi Y, Nishii T, Matsuoka J, Fuyuhiro Y, Shinto O, et
al: Establishment and characterization of a new hypoxia-resistant
cancer cell line, OCUM-12/hypo, derived from a scirrhous gastric
carcinoma. Br J Cancer. 102:898–907. 2010. View Article : Google Scholar : PubMed/NCBI
|
